ISIN | LU1901191145 |
---|---|
Valor Number | 44433882 |
Bloomberg Global ID | |
Fund Name | PROTEA - Veritas High Equity A Acc GBP |
Fund Provider | FundPartner Solutions (Europe) S.A |
Fund Provider | FundPartner Solutions (Europe) S.A |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) |
FundPartner Solutions (Suisse) SA Genève 3 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The Compartment’s objective is to protect and grow the purchasing power of investors’ capital over the long term by seeking global opportunities for real returns and investing on a best ideas, unindexed basis. |
Peculiarities |
Current Price * | 198.32 GBP | 21.11.2024 |
---|---|---|
Previous Price * | 196.40 GBP | 20.11.2024 |
52 Week High * | 199.10 GBP | 13.11.2024 |
52 Week Low * | 166.82 GBP | 28.11.2023 |
NAV * | 198.32 GBP | 21.11.2024 |
Issue Price * | 198.32 GBP | 21.11.2024 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 651,956,289 | |
Unit/Share Assets *** | 313,803,669 | |
Trading Information SIX |
YTD Performance | +14.23% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +19.06% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | +3.60% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | +5.59% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | +8.22% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +18.65% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +27.53% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | +21.28% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +73.04% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UnitedHealth Group Inc | 4.78% | |
---|---|---|
Thermo Fisher Scientific Inc | 4.05% | |
Fiserv Inc | 3.97% | |
Mastercard Inc Class A | 3.80% | |
Marsh & McLennan Companies Inc | 3.79% | |
Intuit Inc | 3.63% | |
Microsoft Corp | 3.63% | |
London Stock Exchange Group PLC | 3.57% | |
Intuitive Surgical Inc | 3.52% | |
Amphenol Corp Class A | 3.44% | |
Last data update | 31.07.2024 |
TER *** | 0.81% |
---|---|
TER date *** | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.75% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |